蛋白及细胞因子 | 北京灵宝科技委托生产,技术转让,CDMO,OEM,ODM,CRO,CMO,菌珠构建,化药合成工艺转让;基因编辑;新药证书转让;临床批件转让;项目融资;CRA;CRC

产品中心

产品编号	产品名称	CAS NO.
ANT- 199	mAMOG
ANT- 150	mAHepatitis B
P0093481	纤溶酶
P0093482	注射用复合辅酶
P0093483	门冬酰胺酶
P0093484	链霉蛋白酶
P0093485	尖吻蝮蛇血凝酶
P0093486	巴曲酶
P0099572	贝伐单抗；Bevacizumab；CAS 216974-75-3
P0099573	西妥昔单抗；Cetuximab；CAS 205923-56-4
P0099574	曲妥珠单抗；Trastuzumab；CAS 180288-69-1
P0099575	利妥昔单抗；Rituximab；CAS 174722-31-7
P0099576	阿达木单抗；Adalimumab；CAS 331731-18-1
P0099577	英夫利昔单抗；Infliximab；CAS 170277-31-3
P0099578	帕妥珠单抗；Pertuzumab；CAS 380610-27-5
P0099579	帕尼单抗；Panitumumab；CAS 339177-26-3
P0099580	地诺单抗；Denosumab；CAS 615258-40-7
P0099581	阿伦单抗；Alemtuzumab；CAS 216503-57-0
P0099582	抗PD-1单抗；Pembrolizumab；CAS 1374853-91-4
P0099583	托西珠单抗/Tocilizumab,Atlizumab /CAS 375823-41-9
P0099584	Atezolizumab；CAS 1380723-44-3
P0099585	Nivolumab/CAS 946414-94-4
P0099586	Obinutuzumab/CAS 949142-50-1
P0099587	Evolocumab/CAS 1256937-27-5
P0099588	Alirocumab/CAS 1245916-14-6
P0099589	lucentis/Ranibizumab/CAS 347396-82-1
P0099590	Xolair/Omalizumab/ CAS 242138-07-4
P0099591	Avelumab,Bavencio,CAS 1537032-82-8
P0099592	Ipilimumab/CAS 477202-00-9
P0099593	Matuzumab/CAS 339186-68-4
P0099594	Aflibercept/CAS 862111-32-8
P0099595	Dulaglutide/CAS 923950-08-7
P0099596	Daratumumab/CAS 945721-28-8
P0099597	Secukinumab/CAS 875356-43-7
P0099598	Eculizumab/CAS 219685-50-4
P0099599	Ustekinumab/CAS 815610-63-0
P0099600	Vedolizumab/CAS 943609-66-3
P0099601	Nimotuzumab/ CAS 828933-51-3/780758-10-3
P0099602	奥法木单抗/Ofatumumab / CAS 679818-59-8
P0099603	Adalimumab	331731-18-1
P0099604	Alemtuzumab	216503-57-0
P0099605	Alirocumab	1245916-14-6
P0099606	Avelumab	1537032-82-8
P0099607	Atezolizumab	1380723-44-3
P0099608	Bevacizumab	216974-75-3
P0099609	Cetuximab	205923-56-4
P0099610	Denosumab	615258-40-7
P0099611	Daratumumab	945721-28-8
P0099612	Eculizumab	219685-50-4
P0099613	Etanercept	185243-69-0
P0099614	Evolocumab	1256937-27-5
P0099615	Infliximab	170277-31-3
P0099616	Ipilimumab	477202-00-9
P0099617	Matuzumab	339186-68-4

第 23 页 / 共 32 页第一页上一页下一页最末页转到